MannKind | MNKD - Ebitda





Ebitda Perubahan Tanggal
Adma Biologics USD 73.59M 14.85M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Eli Lilly USD 12.14B 4.26B 2025-12
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Insmed USD -148.3M 165.88M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
MannKind USD -3.05M 20.97M 2025-12
Merck USD 6.3B 2.09B 2025-12
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Novavax USD 19.36M 190.79M 2025-12
Novo Nordisk DKK 31.44B 6.84B 2025-09
Pfizer USD 5.99B 5.23B 2026-03
Sanofi EUR 3.31B 3.65B 2026-03
Xencor USD -51.05M 55.28M 2025-12